Autopsy report · NCT07529535
A First-in-Human Study of ALK-N001 for Injection in Patients With Advanced Solid Tumors
Cause of deathOther
“Participant recruitment has been stopped because the planned sample size has been reached.”
Life of this trial
- Registered 10 months after it had already started.
- Suspended: paused, and may or may not restart.
- 16 participants enrolled.
Vital statistics
- Status
- Suspended
- Phase
- Phase 1
- Sponsor
- Zhejiang Anglikang Pharmaceutical Co., Ltd.
- Sponsor type
- Industry
- Conditions
- Advance Solid Tumors
- Interventions
- ALK-N001 for Injection
- Participants
- 16
- Sites
- 2
- Countries
- China
Trials that died the same way
- Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.
“Recruitment was stopped before the planned sample size was reached owing to the Covid-19 pandemic and expiration of funding.” - Understanding Hemophilia A and B Drug Dosage Administration Patterns
“Study recruitment was stopped due to difficulty in enrolling the targeted number of patients on March 21, 2018. See details in Description section.” - Intestinal Lavage to Promote Enteral Feeding and Prevent Necrotizing Enterocolitis in Extremely Preterm Infants
“Recruitment was terminated early because of staffing limitations affecting delivery of the intervention, expiration of study funding, and slower-than-anticipated recruitment, which made completion of the planned sample size infeasible.” - Metformin's Effect on Drug Metabolism in Patients With Type 2 Diabetes
“Slow recruitment due to COVID-19, the study was stopped when recruited numbers fulfilled the pre-defined lower sample size.” - Platelet Reactivity With Fentanyl, Morphine, or no Narcotic
“The study was halted prematurely due to difficulties in recruiting a sufficient number of participants. Despite efforts to enroll eligible individuals, the recruitment goals were not met, making it infeasible to continue the study as planned.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.